Alfuzosin hydrochloride
-
Alfuzosin hydrochloride
structure -
-
CAS No:
81403-68-1
-
Formula:
C19H27N5O4.ClH
-
Chemical Name:
Alfuzosin hydrochloride
-
Synonyms:
2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-,hydrochloride (1:1);2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-,monohydrochloride;Alfuzosin hydrochloride;Xatral;Urion;SL 77499-10;Alfoten;SL 77-499-10;Uroxatral;133880-44-1
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Alfuzosin hydrochloride is an α1 adrenergic receptor antagonist used to treat benign prostatic hyperplasia (BPH).Target: α1 adrenergic receptorAlfuzosin, a new quinazoline derivative, acts as a selective and competitive antagonist of alpha 1-adrenoceptor-mediated contraction of prostatic, prostatic capsule, bladder base and proximal urethral smooth muscle, thereby reducing the tone of these structures. Consequently, urethral pressure and resistance, bladder outlet resistance, bladder ins
Characteristics
112
3.12480
White to off-white solid
1.272 g/cm3
225 °C
687.7°C at 760 mmHg
DMSO: >10mg/mL
Store at RT
Safety Information
NONH for all modes of transport
3
22
LT9965475
Xn
P301 + P312 + P330
H302
|Warning|H302 (96.21%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 132 companies from 4 notifications to the ECHA C&L Inventory.
Drug Information
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)|Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Alfetim
Alfuzosin hydrochloride Use and Manufacturing
Preparation of anhydrous Alfuzosin hydrochloride: Alfuzosin base (5g, 0.013mol) is charged to a flask and ethanol (110ml) added. The mixture is refluxed for 15 min. and the solid dissolved. Activated charcoal is added to this solution and the suspension is stirred for lOmin., filtered and washed with 5ml hot ethanol. The filtrate is cooled down to 20-25EXAMPLE 4 [00121] Preparation of Alfuzosin Hydrochloride[00122] Alfuzosin (50.0 g) was suspended in isopropyl alcohol (500.0 ml).Hydrochloric acid in isopropyl alcohol (5-10percent, 100.0 ml) was added to the suspension at EPO [00136] Preparation of Alfuzosin Hydrochloride Anhydrous Polymorph[00137] Alfuzosin (50 g) was suspended in a mixture of ethyl acetate (250 ml) and isopropyl acetate (250 ml). Hydrochloric acid in methanol (5-10percent, 150 ml) was added to the suspension at room temperature. The suspension was stirred at the same temperature EPO EXAMPLE 8; [00124] Preparation of Alfuzosin Hydrochloride[00125] Alfuzosin (50 g) was suspended in a mixture of ethanol (200.0 ml) and methanol (50 ml). Hydrochloric acid in isopropyl alcohol (5-10percent, 100 ml) was added to the suspension at room temperature. The suspension was stirred at same temperature for about 45 to about 60 minutes. The product was isolated by filtration, washed with ethanol (50 ml). The wet product was dried at a temperature ranging from about 50EXAMPLE 3 6 The N-methyl-3-amino-tetrahydrofurancarboxamide 56g (0.30mol) and 2-chloro-4-amino-6, 7-dimethoxyquinazoline 72.2g (0.30mol) in an organic solvent isoamyl alcohol, the mixture was refluxed for 10 hours, cooled and filtered, and the organic solvent was evaporated. The solid was crystallised from diethyl ether and then recrystallization from a mixed solvent, alfuzosin hydrochloride 84.5 g was obtained, the yield was 66percent, and the purity was 97percent.261.4 g (1.40 mol) of N- (3-methylaminopropyl) -2-tetrahydrofurancarboxamide and336.9 g (1.40 mol) of 2-chloro-4-amino-6, 7-dimethoxyquinazoline In the presence of isoamyl alcohol, Stirred at reflux for 6 hours, cooled and filtered, Isoamyl alcohol was removed by rotary evaporation, the solid was dispersed with acetone, Then recrystallized from ethanol-ether, Obtained aloezosin hydrochloride 390.3g, The yield of this step is 65.5percent.
α1-Adrenoceptor antagonist structurally similar to Prozosin. Antihypertensive. Used in treatment of benign prostatic hypertrophy.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:425.9
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:8
Exact Mass:425.1829821
Monoisotopic Mass:425.1829821
Topological Polar Surface Area:112
Heavy Atom Count:29
Complexity:511
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Extract from the above information
Registered Holders
-
APITORIA PHARMA PRIVATE LTD
Active
United States
-
HETERO DRUGS LTD
Active
United Kingdom
-
SANOFI CHIMIE
Active
France
Recommended Suppliers of Alfuzosin hydrochloride
-
CN
3 YRS
Business licensedTrader Supplier of vitaminInquiryCAS No.: 81403-68-1Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 81403-68-1Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 81403-68-1Grade: Industrial GradeContent: 99%
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9